SCHEMBL1386142

SCHEMBL1386142

COC(=O)Nc1ccc(C(=O)C=Cc2cc(N3CCOCC3)c3ccccc3n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MOK Q9UQ07 1/20 0.54
NCF1 P14598 2/20 0.46
PIK3CA P42336 4/20 0.46
MTOR P42345 4/20 0.46
PIK3R1 P27986 3/20 0.46
PDE10A Q9Y233 2/20 0.46
MAPT P10636 5/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
KDM4E B2RXH2 4/20 0.45
HIF1A Q16665 2/20 0.45
MAOB P27338 1/20 0.44
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
MEN1 O00255 1/20 0.44
PKM P14618 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PTGS2 P35354 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1386140 1.00 MOK (0.54) MOKNCF1PIK3CAMTORPIK3R1
SCHEMBL1385160 0.91 MAPT (0.53) MOKNCF1PIK3CAMTORPIK3R1
SCHEMBL1385155 0.91 MAPT (0.53) MOKNCF1PIK3CAMTORPIK3R1
SCHEMBL1385671 0.91 MOK (0.50) MOKNCF1PIK3CAMTORPIK3R1
SCHEMBL1385669 0.91 MOK (0.50) MOKNCF1PIK3CAMTORPIK3R1
SCHEMBL1385196 0.91 MOK (0.55) MOKNCF1PIK3CAMTORPIK3R1
SCHEMBL1385200 0.91 MOK (0.55) MOKNCF1PIK3CAMTORPIK3R1
SCHEMBL1384275 0.89 MOK (0.49) MOKNCF1PIK3CAMTORPIK3R1
SCHEMBL1384278 0.89 MOK (0.49) MOKNCF1PIK3CAMTORPIK3R1
SCHEMBL5090188 0.88 MTOR (0.53) MOKPIK3CAMTORPIK3R1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4790704-B2 2011-10-12 JP claimed
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers TORRENT PHARMACEUTICALS LTD. (IN) 2008-08-28 US claimed
EP-1748987-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS Torrent Pharmaceuticals Ltd (IN) 2007-02-07 EP claimed
WO-2005097746-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS TORRENT PHARMACEUTICALS LTD (IN) 2005-10-20 WO claimed
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers TORRENT PHARMACEUTICALS LTD. (IN) 2008-08-28 US disclosed
EP-1748987-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS Torrent Pharmaceuticals Ltd (IN) 2007-02-07 EP disclosed
WO-2005097746-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS TORRENT PHARMACEUTICALS LTD (IN) 2005-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers HSPB1, HSF1, HSPE1 MOK 3975/4885NCF1 2333/4885PIK3CA 3263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.